| 查看: 489 | 回复: 0 | |||
[交流]
美国休斯顿卫理公会医院肿瘤中心诚招肿瘤分子生物学博后
|
|
One postdoctoral position is available involved in molecular mechanism research of tumor microenvironment in Dr. Jing Yang’s lab at the Houston Methodist Cancer Center. The candidate will be responsible for the projects to identify new biomarkers or therapeutic targets within the bone marrow microenvironment of multiple myeloma for better prevention, diagnosis, or therapy improvement. The translational research program at Dr. Yang’s lab aims to investigate the interplay between cancer cells and bone marrow stromal cells such as adipocytes, immune cells, and bone cells. And the association between obesity and cancer. These studies explore innovative approaches or strategies to prevent therapeutic resistance and improve chemo and immunotherapeutic efficacy and early detection of hematological malignancies. Please refer to the selected publications from Dr. Yang’s lab for more information (Science Translational Medicine (2016, PMID: 27559096); Science Translational Medicine (2019, PMID: 31142679); Cell Metabolism (2021, PMID: 33406405); Nature Communication (2022, PMID: 35760800). We seek a highly motivated and independent candidate with a recent Ph.D. and/or M.D. degree in one of the following (or relevant) areas: oncology, cancer metabolism, or immunology. A candidate with a strong molecular biology background is preferred. The position is opening now until filled. The pay scale follows the NIH guidelines. Interested applications, including curriculum vitae, a brief cover letter, and the contact information of three references should be sent to Dr.Yang: jyang2@houstonmethodist.org. Jing Yang, PhD Associate professor Houston Methodist Cancer Center Weill Cornell Medical College 6550 Fannin St., SM8-023 Houston, TX 77030 |
» 猜你喜欢
建环,能源,土木老师路过看一看!!!
已经有5人回复
一志愿华东理工大学,080500学硕,317分,求调剂
已经有15人回复
初试成绩337找调剂
已经有3人回复
材料专硕 调剂
已经有5人回复
求材料调剂,一志愿郑州大学289分
已经有13人回复
320求调剂
已经有3人回复
一志愿0817化学工程与技术,求调剂
已经有12人回复
土木水利328分求调剂
已经有6人回复
数一英一285求调剂
已经有7人回复
333求调剂
已经有6人回复














回复此楼